- Home
- DGLY vs AIMD Comparison
DGLY vs AIMD Comparison
Compare DGLY & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- AIMD
- Stock Information
- Founded
- DGLY 2004
- AIMD 1984
- Country
- DGLY United States
- AIMD United States
- Employees
- DGLY N/A
- AIMD N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- AIMD Health Care
- Exchange
- DGLY Nasdaq
- AIMD Nasdaq
- Market Cap
- DGLY 6.3M
- AIMD 7.5M
- IPO Year
- DGLY N/A
- AIMD N/A
- Fundamental
- Price
- DGLY $0.03
- AIMD $0.54
- Analyst Decision
- DGLY
- AIMD
- Analyst Count
- DGLY 0
- AIMD 0
- Target Price
- DGLY N/A
- AIMD N/A
- AVG Volume (30 Days)
- DGLY 48.3M
- AIMD 154.6K
- Earning Date
- DGLY 05-16-2025
- AIMD 03-07-2025
- Dividend Yield
- DGLY N/A
- AIMD N/A
- EPS Growth
- DGLY N/A
- AIMD N/A
- EPS
- DGLY N/A
- AIMD N/A
- Revenue
- DGLY $21,131,122.00
- AIMD $20,729.00
- Revenue This Year
- DGLY $22.14
- AIMD N/A
- Revenue Next Year
- DGLY N/A
- AIMD N/A
- P/E Ratio
- DGLY N/A
- AIMD N/A
- Revenue Growth
- DGLY N/A
- AIMD N/A
- 52 Week Low
- DGLY $0.02
- AIMD $0.40
- 52 Week High
- DGLY $3.29
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- DGLY 30.57
- AIMD 51.16
- Support Level
- DGLY $0.03
- AIMD $0.46
- Resistance Level
- DGLY $0.10
- AIMD $0.57
- Average True Range (ATR)
- DGLY 0.01
- AIMD 0.05
- MACD
- DGLY 0.00
- AIMD 0.00
- Stochastic Oscillator
- DGLY 20.73
- AIMD 69.03
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.